Cancer Radiotherapie-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2025-11-30 ms9000000105142041 来自安徽省

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验
经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办

21 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2023-10-16 ms3000001690568501 来自江苏省

偏重的研究方向：回顾性临床研究
经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，

106 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2023-04-14 ms7000001050480020 来自北京

with editor这一步需要多久？

126 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2021-12-28 Mia

摘要撰写有什么套路？有没有模板？

116 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2021-12-27 Gym璨烨

摘要中一定要加入研究目标么？

182 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-05-21 1221bae1m51(暂无昵称)

10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表::
你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表:
你投稿了吗？大约多久接收的？

136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？

181 1 举报

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-03-12 14709675m29(暂无昵称)

你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表:
目前没有版面费的

chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的

157 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-02-13 chunli9219

无版面费yikefanxing 2018-01-10 16:48:00 发表:
CANCER RADIOTHERAPIE有版面费吗？

yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？

197 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2020-02-13 chunli9219

目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表:
CANCER RADIOTHERAPIE有版面费吗？

yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？

173 0 举报

[GetPortalCommentsPageByObjectIdResponse(id=2291207, encodeId=c113229120e89, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：癌症、胶质瘤、治疗、放疗、细胞动物实验 经验分享：投稿改了三版才给送审，一审一个月多点，审稿人大修，编辑拒稿了难办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46429728594, createdName=ms9000000105142041, createdTime=Sun Nov 30 12:32:28 CST 2025, time=2025-11-30, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=2163097, encodeId=e291216309e02, content=偏重的研究方向：回顾性临床研究 经验分享：一审一个审稿人小修，返修后with editor2个半月正常吗。。。。。等得很着急，, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5e76522286, createdName=ms3000001690568501, createdTime=Mon Oct 16 15:54:01 CST 2023, time=2023-10-16, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2125964, encodeId=f560212596442, content=with editor这一步需要多久？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=126, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=dfd38179644, createdName=ms7000001050480020, createdTime=Fri Apr 14 20:22:16 CST 2023, time=2023-04-14, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=1101300, encodeId=1b7611013005e, content=摘要撰写有什么套路？有没有模板？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220301/3a52d3952dde49019f1e000bb5c41d1c/0a0eb7959bb14fcd87745f869bee3c33.jpg, createdBy=46f32239729, createdName=Mia, createdTime=Tue Dec 28 14:52:51 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1101299, encodeId=7bdd1101299d5, content=摘要中一定要加入研究目标么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=182, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:51 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=591371, encodeId=0a9a5913e156, content=10.8投稿，10.29接收136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？136itNr8229(暂无昵称) 2020-03-12 00:00:00 发表: 你投稿了吗？大约多久接收的？, beContent=136itNr8229(暂无昵称) 2020-03-12 发表:: 你投稿了吗？大约多久接收的？, objectType=tool_impact_factor, channel=null, level=null, likeNumber=181, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=65692307077, createdName=1221bae1m51(暂无昵称), createdTime=Thu May 21 00:00:00 CST 2020, time=2020-05-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=586465, encodeId=4f33586465b2, content=你投稿了吗？大约多久接收的？chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, beContent=chunli9219 2020-02-13 00:00:00 发表: 目前没有版面费的, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f55c5186335, createdName=14709675m29(暂无昵称), createdTime=Thu Mar 12 00:00:00 CST 2020, time=2020-03-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584663, encodeId=323f5846639d, content=无版面费yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=197, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=584664, encodeId=283a584664a3, content=目前没有版面费的yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , beContent=yikefanxing 2018-01-10 16:48:00 发表: CANCER RADIOTHERAPIE有版面费吗？ , objectType=tool_impact_factor, channel=null, level=null, likeNumber=173, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=abe72027819, createdName=chunli9219, createdTime=Thu Feb 13 00:00:00 CST 2020, time=2020-02-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=568271, encodeId=a07c5682e152, content=为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=068311864, createdName=panfeihou1979, createdTime=Mon Mar 18 16:59:00 CST 2019, time=2019-03-18, status=1, ipAttribution=)]

2019-03-18 panfeihou1979

为什么我的18年9月投的，现在还是under review，是什么情况？大家有投过的吗

187 0 举报

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务